SCHEMBL24258027

SCHEMBL24258027

O=CC(CO)c1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.46
CYP2C9 P11712 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 2/20 0.46
ACP3 P15309 6/20 0.43
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
SMPD2 O60906 1/20 0.38
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28782552 0.82 ALDH1A1 (0.46) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL614835 0.82 CYP2C9 (0.46) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL3075603 0.77 CYP2C19 (0.41) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL6405535 0.76 ALDH1A1 (0.50) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL28983105 0.76 TSHR (0.44) ALDH1A1HPGDKDM4E
SCHEMBL6005218 0.75 ALDH1A1 (0.54) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL29957205 0.75 ALDH1A1 (0.54) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL9352587 0.75 CYP2C19 (0.54) CYP2C19CYP2C9ALDH1A1CYP1A2ACP3
SCHEMBL25384344 0.75 CYP1A2 (0.49) CYP2C19ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL23904574 0.74 ACP3 (0.40) CYP2C19CYP2C9ALDH1A1ACP3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035805-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed